![](/img/cover-not-exists.png)
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
R. Gniadecki, K. Kragballe, T.N. Dam, L. SkovVolume:
164
Year:
2011
Language:
english
Pages:
6
DOI:
10.1111/j.1365-2133.2011.10213.x
File:
PDF, 175 KB
english, 2011